TheProfitWatch

SLNO - Soleno Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
44.95 0.17 (0.38%) -0.05 (-0.11%) -0.12 (-0.27%) -0.25 (-0.55%) 0.43 (0.96%) 0.57 (1.28%) 0.0 (0.0%) 1.65 (3.77%)

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Category: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-501.3333
Diluted P/E:
-501.3333
RSI(14) 1m:
54.39
VWAP:
45.13
RVol:

Events

Period Kind Movement Occurred At

Related News